IP Library › Granted Patent US 8,043,620
Granted Patent B2
US 8,043,620 · App. 12/275,850 · Granted Oct 25, 2011

Wise binding agents and epitopes

Assignee: Amgen Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,043,620
App. No.
12/275,850
Granted
Oct 25, 2011
Kind
B2
Abstract

The present invention relates to binding agents for WISE, and includes for their manufacture and use.

Claims (5)

1. An isolated antibody or fragment thereof that binds WISE, wherein the heavy chain of said antibody comprises SEQ ID NO: 24.

2. An antibody or fragment thereof according to claim 1 in combination with one or more of a pharmaceutically acceptable excipient, diluent or carrier.

3. An antibody or fragment thereof according to claim 1 conjugated to at least one of Fc, PEG, albumin, and transferrin.

4. An antibody or fragment thereof of claim 1 comprising a light chain selected from the group consisting of SEQ ID NOs: 22, 46, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, and 122.

5. An antibody or fragment thereof of claim 1 that inhibits WISE activity.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2008
From: QIAN, XUEMING; GRAHAM, KEVIN; SHIMAMOTO, GRANT; TIPTON, BARBARA S.; TSAI, MEI-MEI; WINTERS, AARON GEORGE; ZHANG, LI
To: AMGEN INC.
Reel/Frame 021878/0158 →
Continuity (2)
Provisional Application 61004037 · Nov 21, 2007
Related Publication 20090130114A1 · May 21, 2009